Costache Andrei, Riza Anca-Lelia, Popescu Mihaela, Dinca Mihaela-Eugenia, Glavan Daniela-Gabriela, Vladu Ionela-Mihaela, Ioana Mihai, Udristoiu Ion
University of Medicine and Pharmacy of Craiova, Romania.
Regional Center of Medical Genetics Craiova, County Emergency Hospital, Craiova, Romania.
Curr Health Sci J. 2020 Apr-Jun;46(2):117-122. doi: 10.12865/CHSJ.46.02.03. Epub 2020 Jun 30.
Depression is a significant contributor to the overall burden of disease on a global scale. Thyroid hormones thyroxine (T4) and triiodothyronine (T3) have been shown to play a critical role in the development and normal function of the brain. It has been suggested that dysregulation of thyroid function could be associated with depression, especially hypothyroidism, but not all studies support this hypothesis. We enrolled a cohort of 96 subjects with major depressive disorder and tested TSH and FT4 levels for 80 of them in order to assess the status of the hypothalamic-pituitary-thyroid axis (HPT). We found 7 cases (8.75% of the tested) of subclinical hyperthyroidism and 1 case (1.25%) of overt hyperthyroidism. While we did not find supporting evidence for association between TSH and FT4 levels and depression, our findings question whether screening depressive patients for HPT axis anomalies could be clinically relevant, if anything, in a regional context.
抑郁症是全球疾病总负担的一个重要因素。甲状腺激素甲状腺素(T4)和三碘甲状腺原氨酸(T3)已被证明在大脑的发育和正常功能中起关键作用。有人提出,甲状腺功能失调可能与抑郁症有关,尤其是甲状腺功能减退,但并非所有研究都支持这一假设。我们招募了96名患有重度抑郁症的受试者,并对其中80人进行了促甲状腺激素(TSH)和游离甲状腺素(FT4)水平检测,以评估下丘脑 - 垂体 - 甲状腺轴(HPT)的状态。我们发现了7例亚临床甲状腺功能亢进(占检测人数的8.75%)和1例显性甲状腺功能亢进(占1.25%)。虽然我们没有找到TSH和FT4水平与抑郁症之间存在关联的支持证据,但我们的研究结果引发了一个问题,即在区域范围内,筛查抑郁症患者的HPT轴异常在临床上是否具有相关性(如果有的话)。